These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1582012

  • 41. Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure.
    Worth GK, Vasikaran SD, Retallack RW, Musk AA, Gutteridge DH.
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):149-54. PubMed ID: 15025807
    [Abstract] [Full Text] [Related]

  • 42. Parathyrin radioimmunoassay: diagnostic utility of antisera produced against carboxyl-terminal fragments of the hormone from the human.
    Di Bella FP, Kehrwald JM, Laakso K, Zitzner L.
    Clin Chem; 1978 Mar; 24(3):451-4. PubMed ID: 564762
    [Abstract] [Full Text] [Related]

  • 43. Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone.
    St John A, Davies C, Riley WJ, Kent GN, Brown RC, Aston JP, Weeks I, Woodhead JS.
    Clin Chim Acta; 1988 Dec 15; 178(2):215-23. PubMed ID: 3242983
    [Abstract] [Full Text] [Related]

  • 44. Development and validation of a new radioimmunoassay for parathyrin (PTH).
    Kao PC, Jiang NS, Klee GG, Purnell DC.
    Clin Chem; 1982 Jan 15; 28(1):69-74. PubMed ID: 7055938
    [Abstract] [Full Text] [Related]

  • 45. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
    Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP.
    J Clin Endocrinol Metab; 2003 Oct 15; 88(10):4725-30. PubMed ID: 14557447
    [Abstract] [Full Text] [Related]

  • 46. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.
    Pandian MR, Morgan CH, Carlton E, Segre GV.
    Clin Chem; 1992 Feb 15; 38(2):282-8. PubMed ID: 1371724
    [Abstract] [Full Text] [Related]

  • 47. Individual and combined effects of intact PTH, amino-terminal, and a series of truncated carboxyl-terminal PTH fragments on alkaline phosphatase activity in dexamethasone-treated rat osteoblastic osteosarcoma cells, ROS 17/2.8.
    Nakamoto C, Baba H, Fukase M, Nakajima K, Kimura T, Sakakibara S, Fujita T, Chihara K.
    Acta Endocrinol (Copenh); 1993 Apr 15; 128(4):367-72. PubMed ID: 8498156
    [Abstract] [Full Text] [Related]

  • 48. Intact parathyroid hormone in primary hyperparathyroidism.
    Flentje D, Schmidt-Gayk H, Fischer S, Stern J, Blind E, Buhr H, Herfarth C.
    Br J Surg; 1990 Feb 15; 77(2):168-72. PubMed ID: 2317677
    [Abstract] [Full Text] [Related]

  • 49. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT, Silva MC, Peres RB, Ferreira SR, Draibe SA, Vieira JG.
    Braz J Med Biol Res; 1990 Feb 15; 23(3-4):235-43. PubMed ID: 2094538
    [Abstract] [Full Text] [Related]

  • 50. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.
    Inaba M, Nakatsuka K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y.
    Clin Chem; 2004 Feb 15; 50(2):385-90. PubMed ID: 14684623
    [Abstract] [Full Text] [Related]

  • 51. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
    Godber IM, Parker CR, Lawson N, Hitch T, Porter CJ, Roe SD, Cassidy MJ, Hosking DJ.
    Ann Clin Biochem; 2002 May 15; 39(Pt 3):314-7. PubMed ID: 12038608
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Superiority of dynamic over static reference intervals for intact, midmolecule, and C-terminal parathyrin in evaluating calcemic disorders.
    Lepage R, Whittom S, Bertrand S, Bahsali G, D'Amour P.
    Clin Chem; 1992 Oct 15; 38(10):2129-35. PubMed ID: 1395006
    [Abstract] [Full Text] [Related]

  • 54. C-terminal parathyrin (parathyroid hormone) radioimmunoassay in serum with commercially available reagents.
    Simon M, Cuan J.
    Clin Chem; 1980 Nov 15; 26(12):1666-71. PubMed ID: 7428149
    [Abstract] [Full Text] [Related]

  • 55. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
    Coen G, Mazzaferro S, Ballanti P, Bonucci E, Cinotti GA, Fondi G, Manni M, Pasquali M, Perruzza I, Sardella D.
    J Lab Clin Med; 1993 Jul 15; 122(1):103-9. PubMed ID: 8320484
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.
    Rubin MR, Silverberg SJ, D'Amour P, Brossard JH, Rousseau L, Sliney J, Cantor T, Bilezikian JP.
    Clin Chem; 2007 Aug 15; 53(8):1470-6. PubMed ID: 17599957
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM, Gordeladze JO, Moxheim E, Gautvik VT.
    Eur Surg Res; 1984 Aug 15; 16 Suppl 2():41-54. PubMed ID: 6723731
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.